Shozo Kobori

978 total citations
36 papers, 863 citations indexed

About

Shozo Kobori is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Shozo Kobori has authored 36 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Cancer Research. Recurrent topics in Shozo Kobori's work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Shozo Kobori is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Shozo Kobori collaborates with scholars based in Japan and United States. Shozo Kobori's co-authors include Motoaki Shichiri, Masakazu Sakai, Seikoh Horiuchi, Hideki Hakamata, Takeshi Matsumura, Akira Miyazaki, Toru Takemura, Hirofumi Matsuda, Takeshi Biwa and Yoshihiro Sato and has published in prestigious journals such as Journal of Biological Chemistry, Kidney International and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Shozo Kobori

35 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shozo Kobori Japan	15	332	266	250	175	151	36	863
T Mazzone United States	21	575 1.7×	479 1.8×	274 1.1×	295 1.7×	173 1.1×	31	1.2k
Gertie Gorter Netherlands	23	283 0.9×	412 1.5×	151 0.6×	189 1.1×	108 0.7×	51	1.3k
J. H. Qiao United States	11	425 1.3×	483 1.8×	695 2.8×	171 1.0×	333 2.2×	20	1.5k
Toshiyuki Ishibashi Japan	19	229 0.7×	302 1.1×	271 1.1×	76 0.4×	93 0.6×	61	1.0k
Chu Kataoka Japan	14	312 0.9×	390 1.5×	389 1.6×	98 0.6×	128 0.8×	17	1.3k
Karin Toet Netherlands	20	235 0.7×	451 1.7×	107 0.4×	116 0.7×	266 1.8×	30	1.1k
Patti Polinsky United States	7	197 0.6×	140 0.5×	254 1.0×	129 0.7×	98 0.6×	8	697
Dale Newland United States	10	543 1.6×	425 1.6×	350 1.4×	177 1.0×	196 1.3×	14	1.2k
Yumiko Nakagawa-Toyama Japan	16	493 1.5×	288 1.1×	158 0.6×	218 1.2×	169 1.1×	24	919
G. Tibolla Italy	13	540 1.6×	256 1.0×	226 0.9×	218 1.2×	112 0.7×	21	1.1k

Countries citing papers authored by Shozo Kobori

Since Specialization

Citations

This map shows the geographic impact of Shozo Kobori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shozo Kobori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shozo Kobori more than expected).

Fields of papers citing papers by Shozo Kobori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shozo Kobori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shozo Kobori. The network helps show where Shozo Kobori may publish in the future.

Co-authorship network of co-authors of Shozo Kobori

This figure shows the co-authorship network connecting the top 25 collaborators of Shozo Kobori. A scholar is included among the top collaborators of Shozo Kobori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shozo Kobori. Shozo Kobori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Takeshi, Masahiro Harada, Makoto Ujihara, et al.. (2013). Prevalence of metabolic syndrome in stroke patients: a prospective multicenter study in Japan. Acute Medicine & Surgery. 1(1). 17–22. 2 indexed citations

Takahashi, Takeshi, et al.. (2005). HMG-CoA Reductase Inhibitors Suppress the Development and Progression of Carotid Artery Intimal-medial Thickening in Hypercholesterolemic Type 2 Diabetic Patients. Journal of Atherosclerosis and Thrombosis. 12(3). 149–153. 12 indexed citations

Takahashi, Takeshi, et al.. (2002). Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. Diabetes Research and Clinical Practice. 58(2). 123–129. 60 indexed citations

Biwa, Takeshi, Masakazu Sakai, Takeshi Matsumura, et al.. (2000). Sites of Action of Protein Kinase C and Phosphatidylinositol 3-Kinase Are Distinct in Oxidized Low Density Lipoprotein-induced Macrophage Proliferation. Journal of Biological Chemistry. 275(8). 5810–5816. 29 indexed citations

Sakai, Masakazu, et al.. (2000). Macrophage proliferation in atherosclerosis. Current Opinion in Lipidology. 11(5). 503–509. 46 indexed citations

Sasaki, Junichi, et al.. (1998). A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia. Clinical Therapeutics. 20(3). 539–548. 8 indexed citations

Yano, Toshihiro, et al.. (1997). β-very low density lipoprotein induces triglyceride accumulation through receptor mediated endocytotic pathway in 3T3-L1 adipocytes. Atherosclerosis. 135(1). 57–64. 12 indexed citations

Matsuda, Hirofumi, Hideki Hakamata, Akira Miyazaki, et al.. (1996). Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1301(1-2). 76–84. 35 indexed citations

Sato, Yoshihiro, Shozo Kobori, Masakazu Sakai, et al.. (1996). Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation. Atherosclerosis. 125(1). 15–26. 21 indexed citations

10.

Takeda, Haruo, Takayuki Higashi, Takeshi Nishikawa, et al.. (1996). Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro. Diabetes Research and Clinical Practice. 31(1-3). 1–8. 6 indexed citations

11.

Sakai, Masakazu, Akira Miyazaki, Hideki Hakamata, et al.. (1996). Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages. Atherosclerosis. 119(2). 191–202. 7 indexed citations

12.

Sakai, Masakazu, Akira Miyazaki, Hideki Hakamata, et al.. (1996). Endocytic Uptake of Lysophosphatidylcholine Mediated by Macrophage Scavenger Receptor Plays a Major Role in Oxidized Low Density Lipoprotein-induced Macrophage Growth. Journal of Atherosclerosis and Thrombosis. 2(2). 81–86. 8 indexed citations

13.

Sasahara, Takayuki, Shozo Kobori, Yoshihiro Sato, et al.. (1994). The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux. Atherosclerosis. 106(2). 179–190. 9 indexed citations

14.

Takeda, Haruo, Hideki Kishikawa, Takao MIYATA, et al.. (1992). Abnormalities in Platelets and Vascular Endothelial Cells Induced by Glycated Lipoproteins.. Internal Medicine. 31(6). 746–751. 3 indexed citations

15.

Takeda, Haruo, et al.. (1990). Glycation of Serum High-and Low-Density Lipoproteins in Diabetic Subjects. 33(10). 799–803. 1 indexed citations

16.

Kobori, Shozo, Haruo Takeda, Seiji Fukuda, et al.. (1990). Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus. Atherosclerosis. 80(3). 181–189. 53 indexed citations

17.

Kobori, Shozo, Mitsuko Okada, Hirotada Mori, et al.. (1989). Identification of Human Apolipoprotein E Variant Gene: Apolipoprotein E7 (Glu244,245↑Lys244,245)1. The Journal of Biochemistry. 105(1). 51–54. 23 indexed citations

18.

Nakamura, Nobuhisa, Haruo UZAWA, Shozo Kobori, & Haruo Takeda. (1987). Serum Lipids Profiles and Nutritional Survey. Journal of Clinical Biochemistry and Nutrition. 2(3). 233–243. 1 indexed citations

19.

Kobori, Shozo, et al.. (1986). A kindred of familial combined hyperlipidemia (FCHL) with proband showing type V hyperlipoproteinemia.. Japanese Journal of Medicine. 25(3). 306–312. 2 indexed citations

20.

Kobori, Shozo, et al.. (1983). Hydrolysis of succinyl-trialanine p-nitroanilide by two enzymes associated with human high-density lipoproteins. Archives of Biochemistry and Biophysics. 226(2). 629–635. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact